Protective effect of the tachykinin NK2 receptor antagonist nepadutant in acute rectocolitis induced by diluted acetic acid in guinea-pigs.
We have evaluated the potential protective activity of nepadutant, a selective tachykinin NK2 receptor antagonist, in a model of acute rectocolitis induced by an enema with 7.5% acetic acid in guinea-pigs. The injury was quantified visually by using a macroscopic injury score, and histologically by using a necrosis score. In addition, changes in myeloperoxidase activity, a marker for neutrophil infiltration, and plasma protein extravasation were evaluated. The injury caused by 7.5% acetic acid was mild, affecting the superficial layers and producing a strong edema of the submucosa. A single administration of nepadutant (0.3-10 mg/kg s.c., 1 h before acetic acid) markedly reduced the macroscopic damage and necrosis score and the increase in plasma protein extravasation induced by 7.5% acetic acid in the early phase of the injury. Single administration of nepadutant (3 mg/kg s.c.) reduced the macroscopic score and myeloperoxidase activity at the top (24 h) of inflammation. Repeated administration (3 mg/kg s.c. three times during 24 h) or co-administration of the tachykinin NK1 receptor antagonist MEN 11467 (3 mg/kg s.c.) did not enhance the antiulcer effect obtained with the single treatment with nepadutant. These data suggest the involvement of tachykinin NK2 receptors in the first phases of inflammation induced by acetic acid.
Cutrufo
C
C
Menarini Ricerche spa, Pharmacology and Preclinical Development Departments, Firenze, Italy.
Evangelista
S
S
Cirillo
R
R
Ciucci
A
A
Conte
B
B
Lopez
G
G
Manzini
S
S
Maggi
C A
CA
D019342:Acetic Acid / Q000633:toxicity; D000818:Animals; D003514:Cyclohexylamines / Q000494:pharmacology; D006168:Guinea Pigs; D007211:Indoles / Q000494:pharmacology; D008297:Male; D064729:Neurokinin-1 Receptor Antagonists; D010456:Peptides, Cyclic / Q000494:pharmacology / Q000627:therapeutic use*; D009195:Peroxidase / Q000032:analysis; D011350:Proctocolitis / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D018041:Receptors, Neurokinin-2 / Q000037:antagonists & inhibitors*; D015320:Tachykinins / Q000502:physiology*
D003514:Cyclohexylamines; D007211:Indoles; C107754:MEN 11420; C121095:MEN 11467; D064729:Neurokinin-1 Receptor Antagonists; D010456:Peptides, Cyclic; D018041:Receptors, Neurokinin-2; D015320:Tachykinins; D009195:Peroxidase; D019342:Acetic Acid